• Study on Ustekinumab and Drug Combination for Patients with Severe, Resistant Inflammatory Disease

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Spironolactone for Treating Active Rheumatoid Arthritis in Patients

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany

  • Study on the Effect of Ovarian Stimulation Intensity Using Clomifene Citrate and Follitropin Alfa in Women with Infertility and Suboptimal Response

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on How Antibiotics Work in the Spinal Fluid of Children with Brain Drains: Cefuroxime, Vancomycin, and Gentamicin with a Drug Combination

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Austria

  • Study of treatment discontinuation with nilotinib and asciminib in adults with chronic myeloid leukemia to achieve treatment-free remission

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on the Effects of TAK-341 for Patients with Multiple System Atrophy

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Denmark France Germany Italy Portugal +1

  • Study on the Safety and Effects of Tolinapant in Patients with Advanced Solid Tumors and Lymphomas

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Spain

  • Study on Axatilimab and Ruxolitinib for Patients with Newly Diagnosed Chronic Graft-Versus-Host Disease

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Germany Italy Spain

  • Study on the Effects of Satralizumab in Children and Adolescents with Duchenne Muscular Dystrophy

    Not recruiting

    2 1 1
    Investigated diseases:
    Denmark Italy Poland Spain

  • Study on the Effects and Safety of Camizestrant (AZD9833) Compared to Fulvestrant in Postmenopausal Women with Advanced ER-Positive HER2-Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Hungary Italy Poland Portugal +1

powered by